Fourth quarter sales grew 15.1% to a record $240.1 million driven by record Aerospace sales of $219.6 million, a 16.5% year over year increase
Achieved fourth quarter net income of $29.6 million, or $0.78 per diluted share; adjusted EBITDA¹ was $45.7 million, or 19.0% of sales
Aerospace operating margin expanded to 19.0%, bolstered by favorable mix; adjusted Aerospace operating margin¹ was 19.8%
Booked $257.2 million in orders; ended 2025 with record backlog of $674.5 million
Solid cash generation with $27.6 million in cash from operations in the quarter and $74.8 million for the year
Maintained 2026 revenue guidance at $950 million to $990 million

Astronics Corporation (NASDAQ:ATRO) ("Astronics" or the "Company"), a leading supplier of advanced technologies and products to the global aerospace, defense, and other mission critical industries, today reported financial results for the three and twelve months ended December 31, 2025. Financial results include the acquisition of Bühler Motor Aviation ("BMA") on October 13, 2025.

Peter J. Gundermann, Chairman, President and Chief Executive Officer, commented, "We made excellent progress in 2025 and ended the year with a strong fourth quarter. Robust demand across our aerospace markets drove record sales in the quarter. In addition, the acquisition of BMA advanced our market leadership position in seat actuation and other motion systems for aircraft. Our growth is translating well to stronger profitability. Operating margin expanded nicely on higher volumes and was supported as well by pricing initiatives, operating efficiencies and favorable mix. We also generated strong cash flow from operations of $27.6 million in the quarter. We ended 2025 with record backlog, better operating efficiencies, lower cost debt and a solid liquidity position, all of which positions us well for the opportunities we see in 2026."

Fourth Quarter Results

	Three Months Ended								Year Ended
*($ in thousands)*	December 31, 2025			December 31, 2024			% Change		December 31, 2025			December 31, 2024			% Change

Sales	$	240,067		$	208,540		15.1	%	$	862,128		$	795,426		8.4	%
Gross profit	$	79,971		$	62,122		28.7	%	$	258,158		$	220,428		17.1	%
Gross margin		33.3	%		29.8	%				29.9	%		27.7	%
Income from operations	$	35,462		$	8,876		299.5	%	$	76,412		$	26,466		188.7	%
Operating margin %		14.8	%		4.3	%				8.9	%		3.3	%
Loss on settlement of debt	$	—		$	3,161				$	32,644		$	10,148
Net income (loss)	$	29,615		$	(2,832	)	1,145.7	%	$	29,359		$	(16,215	)	281.1	%
Net income (loss) %		12.3	%		(1.4	)%				3.4	%		(2.0	)%

Adjusted operating income²	$	38,330		$	23,837		60.8	%	$	105,163		$	61,538		70.9	%
Adjusted operating margin %²		16.0	%		11.4	%				12.2	%		7.7	%
Adjusted net income²	$	28,516		$	16,849		69.2	%	$	78,634		$	38,136		106.2	%
Adjusted EBITDA²	$	45,673		$	31,539		44.8	%	$	134,538		$	96,466		39.5	%
Adjusted EBITDA margin %²		19.0	%		15.1	%				15.6	%		12.1	%

Fourth Quarter 2025 Results (compared with the prior-year period, unless noted otherwise)

Growth in sales was driven by continued strength in demand for the Aerospace segment primarily from the Commercial Transport market. Aerospace sales increased $31.0 million, or 16.5%, and Test Systems sales increased $0.5 million.

Gross profit increased $17.8 million to $80.0 million, or 33.3% of sales, a 350 basis point expansion over gross margin of 29.8% in the comparator quarter. Margin expansion was driven by higher volume, favorable mix, pricing actions including some true up pricing recovery, improved productivity, and the benefit of Test Systems' restructuring initiatives. This more than offset a $2.9 million increase in tariff expense.

In the fourth quarter of 2025, selling, general and administrative expenses ("SG&A") decreased $7.3 million primarily from a $9.0 million reduction in legal reserves and litigation-related expenses, somewhat offset by SG&A associated with the acquired BMA business and higher legal and accounting expenses related to the acquisition. R&D was $1.4 million lower reflecting the timing of projects.

Higher gross profit and reduced SG&A resulted in operating margin of 14.8% compared with 4.3% in the prior-year period. Adjusted operating margin² expanded 450 basis points.

Interest expense was down $0.8 million, or 18.5%, on lower rates following 2025 refinancing activities. The fourth quarter included $0.6 million in expense related to the write-off of deferred financing fees related to two exiting revolving credit facility lenders, classified within interest expense.

Tax expense in the quarter was $2.6 million compared with $3.4 million in the prior-year period, mostly because of a valuation allowance reversal associated with research and development costs that are expected to be expensed for tax purposes in the current year under the One Big Beautiful Bill Act.

Consolidated net income of $0.78 per diluted share improved from a net loss of $0.08 per diluted share in the prior-year period due to stronger operating profit and lower interest expense. Adjusted diluted earnings per share² increased $0.29 per diluted share, or 62.5%, to $0.75 per diluted share. Adjusted EBITDA² increased 44.8% to $45.7 million, and adjusted EBITDA margin²expanded 390 basis points to 19.0% of consolidated sales.

Bookings were up 31.3% to $257.2 million in the quarter. For the year, bookings grew 14.4% to $924.4 million with a book-to-bill ratio of 1.07:1. Backlog at the end of the quarter was $674.5 million, the highest recorded in Company's history.

Aerospace Segment Review (compared with the prior-year period, unless noted otherwise)

Record Aerospace segment sales of $219.6 million were up $31.0 million, or 16.5%. Sales in the Commercial Transport market grew $26.1 million, or 18.5%. Growth was primarily related to increased demand by airlines for cabin power, seat motion, lighting and safety and system certification products and services, partially offset by lower demand for avionics products. Military Aircraft sales increased $3.6 million, or 14.5%, to $28.0 million, driven by pricing initiatives, increased demand for lighting and safety products, and continued progress on MV-75 engineering efforts. General Aviation sales were up $4.6 million, or 26.0%, to $22.3 million due to higher inflight entertainment & connectivity ("IFEC") product sales to the VVIP market. Other sales were down $3.2 million as the Company has wound down its non-core contract manufacturing arrangements.

Aerospace segment operating profit of $41.7 million, or 19.0% of sales, measurably improved over the prior-year period reflecting the leverage gained on higher volume, favorable mix, pricing initiatives, and improving production efficiencies. The quarter also benefitted from a $9.3 million decrease in litigation-related reserves and expenses. Adjusted Aerospace operating profit² increased 44.1% to $43.6 million, or 19.8% of sales, a 380-basis point expansion over the comparator quarter.

Aerospace bookings were up 30.1% to $237.3 million for a book-to-bill ratio of 1.08:1. Backlog for the Aerospace segment was $600.8 million at the end of 2025 which was an 11.8% increase over backlog at the end of 2024 and a 5.0% increase over the trailing third quarter.

Mr. Gundermann commented, "Our Aerospace business had a strong fourth quarter with record sales that led to a 19.0% operating margin, surpassing our near-term margin target and a testament to its potential. In addition to higher volume, profitability benefitted from a favorable mix within our VVIP market as well as with some recovery related to pricing initiatives. We have very strong tailwinds supporting our Aerospace business that we believe will continue to drive strong results in 2026 and beyond."

Test Systems Segment Review (compared with the prior-year period, unless noted otherwise)

Test Systems segment sales were $20.5 million, up $0.5 million from the comparator quarter in 2024.

Test Systems segment operating profit was $1.1 million compared with slightly below break-even in the fourth quarter of 2024. The comparator quarter included $1.4 million in expenses related to simplification and restructuring activities which contributed to the profit improvement at this sales level. Test Systems continued to be negatively affected by mix and under absorption of fixed costs at current volume levels.

Bookings for the Test Systems segment in the quarter were $19.9 million, for a book-to-bill ratio of 0.97:1 for the quarter. Backlog was $73.7 million at the end of 2025.

Mr. Gundermann commented, "Our Test business generated operating profit on relatively low sales, which demonstrates the significant cost-cutting initiatives we have implemented across the business. We expect its level of profitability will meaningfully improve once production for the U.S. Army radio test program begins. At this time, we believe we will receive production orders for that program early in the second quarter or soon thereafter."

Balance Sheet and Liquidity

Cash provided by operations in the fourth quarter of 2025 was $27.6 million, reflecting higher cash earnings, offset by higher working capital requirements associated with increased order volume. Capital expenditures in the quarter were $11.8 million and $31.7 million for the full year. Elevated capital expenditures in 2025 reflect the investments made on previously deferred spending as well as the consolidation of operations in a new Seattle facility.

Long-term debt, net of cash, increased $168.2 million to $324.8 million at the end of 2025 compared with $156.6 million. Debt was higher due to the refinancing actions that resulted in the repurchase of 80% of the $165 million 5.5% convertible bonds. The refinancing was accomplished through the issue of $225 million of 0% convertible bonds and included the purchase of a capped call.

On October 22, 2025, the Company entered into a new $300 million senior secured, cash flow-based revolving credit facility (the "New Revolver") which matures in October 2030. The New Revolver includes a $100 million accordion feature which can be incrementally expanded if maximum leverage requirements are met.

The Company had available liquidity of $230.9 million including $18.2 million in cash at the end of 2025.

2026 Outlook

The Company expects 2026 revenue to be approximately $950 million to $990 million. The midpoint of this range would be a 13% increase over 2025 sales. The Company expects first quarter revenue to be approximately $220 million to $230 million, up 9% at the midpoint of the range over the prior-year period.

Backlog at December 31, 2025 was a record $674.5 million, of which approximately 79% is expected to be recognized as revenue over the next twelve months. Planned capital expenditures in 2026 are expected to be in the range of $40 million to $50 million and include the remaining costs associated with the Seattle operation consolidation. In addition, the Company plans to invest approximately $14 million to $18 million in 2026 for the implementation of a global enterprise resource planning system. The investment will be reported as a cash outflow from operations, rather than as a capital expenditure.

Mr. Gundermann concluded, "We expect 2026 will be another very strong year with double digit growth, weighted slightly toward the second half. Our future is very bright. We have a long runway of opportunities on which to execute and are very excited about 2026 and beyond. We are also striving to consistently deliver high-teens operating margins for the consolidated business which should be realizable with the expected improvement with the Test business. In all, we expect we will continue to create more value for our customers, shareholders and the Astronics team."

Fourth Quarter 2025 Webcast and Conference Call

The Company will host a teleconference today at 4:45 p.m. ET. During the teleconference, management will review the financial and operating results for the period and discuss Astronics' corporate strategy and outlook. A question-and-answer session will follow.

The Astronics conference call can be accessed by calling (201) 493-6784. The listen-only audio webcast can be monitored at investors.astronics.com. To listen to the archived call, dial (412) 317-6671 and enter replay pin number 13758335. The telephonic replay will be available from 8:00 p.m. on the day of the call through Tuesday, March 10, 2026. The webcast replay can be accessed via the investor relations section of the Company's website where a transcript will also be posted once available.

About Astronics Corporation

Astronics Corporation (NASDAQ:ATRO) serves the world's aerospace, defense, and other mission-critical industries with proven innovative technology solutions. Astronics works side-by-side with customers, integrating its array of power, connectivity, lighting, structures, interiors, and test technologies to solve complex challenges. For over 50 years, Astronics has delivered creative, customer-focused solutions with exceptional responsiveness. Today, global airframe manufacturers, airlines, military branches, completion centers, and Fortune 500 companies rely on the collaborative spirit and innovation of Astronics. The Company's strategy is to increase its value by developing technologies and capabilities that provide innovative solutions to its targeted markets.

Safe Harbor Statement

This news release contains forward-looking statements as defined by the Securities Exchange Act of 1934. One can identify these forward-looking statements by the use of the words "expect," "anticipate," "plan," "may," "will," "estimate," "feeling" or other similar expressions and include all statements with regard to the Company's 2026 and first quarter revenue outlook, the amount of revenue in the second half of 2026, the ability to deliver high-teens operating margins for the consolidated business, the amount of capital expenditures for 2026 as well as the amount of investment in an ERP system, the amount of backlog to be recognized as revenue over the next twelve months, the strength and length of time associated with tailwinds for the Aerospace segment, the timing of the receipt of production orders for U.S. Army radio test set program and the level of profitability contribution from the Test segment with its onset, the amount of opportunities available to be executed, the ability to achieve high-teen operating margins on a consolidated basis consistently, and statements regarding the strategy of the Company and its outlook. Forward-looking statements also include all statements related to achieving any revenue or profitability expectations, expectations of continued growth, the level of liquidity, the level of cash generation, the level of demand by customers and markets and the amount of expected capital expenditures. Because such statements apply to future events, they are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated by the statements. Important factors that could cause actual results to differ materially from what may be stated here include the trend in growth with passenger power and connectivity on airplanes, the state of the aerospace and defense industries, the market acceptance of newly developed products, internal production capabilities, the timing of orders received, the status of customer certification processes and delivery schedules, the demand for and market acceptance of new or existing aircraft which contain the Company's products, the impact of regulatory activity and public scrutiny on production rates of a major U.S. aircraft manufacturer, the need for new and advanced test equipment, customer preferences and relationships, the effectiveness of the Company's supply chain, and other factors which are described in filings by Astronics with the Securities and Exchange Commission. Except as required by applicable law, the Company assumes no obligation to update forward-looking information in this news release whether to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial conditions or prospects, or otherwise.

Use of Non-GAAP Financial Metrics and Additional Financial Information

In addition to reporting financial results in accordance with generally accepted accounting principles, or GAAP, Astronics provides Adjusted Non-GAAP information as additional information for its operating results. References to Adjusted Non-GAAP information are to non-GAAP financial measures. These measures are not required by, in accordance with, or an alternative for, GAAP and may be different from non-GAAP financial measures used by other companies. Astronics management uses these measures for reviewing the financial results of Astronics for budget planning purposes and for making operational and financial decisions. Management believes that providing these non-GAAP financial measures to investors, as a supplement to GAAP financial measures, help investors evaluate Astronics core operating and financial performance and business trends consistent with how management evaluates such performance and trends.

FINANCIAL TABLES FOLLOW

ASTRONICS CORPORATION
CONSOLIDATED STATEMENT OF OPERATIONS DATA
(Unaudited, $ in thousands except per share data)

	Three Months Ended						Year Ended
	12/31/2025			12/31/2024			12/31/2025			12/31/2024
Sales	$	240,067		$	208,540		$	862,128		$	795,426
Cost of products sold		160,096			146,418			603,970			574,998
Gross profit³		79,971			62,122			258,158			220,428
*Gross margin*		*33.3*	%		*29.8*	%		*29.9*	%		*27.7*	%

Research and development expenses		10,626			12,068			43,475			52,086
Selling, general and administrative		33,883			41,178			138,271			141,876
*SG&A % of sales*		*14.1*	%		*19.7*	%		*16.0*	%		*17.8*	%
Income from operations		35,462			8,876			76,412			26,466
*Operating margin*		*14.8*	%		*4.3*	%		*8.9*	%		*3.3*	%

Loss on settlement of debt		—			3,161			32,644			10,148
Other (income) expense		(176	)		973			(738	)		2,187
Interest expense, net		3,394			4,166			12,561			21,998
Income (loss) before tax		32,244			576			31,945			(7,867	)
Income tax expense		2,629			3,408			2,586			8,348
Net income (loss)	$	29,615		$	(2,832	)	$	29,359		$	(16,215	)
*Net income (loss) %*		*12.3*	%		*(1.4*	)%		*3.4*	%		*(2.0*	)%

Basic earnings (loss) per share:	$	0.83		$	(0.08	)	$	0.83		$	(0.46	)

Convertible notes interest expense, net		358			—			—			—
Net income (loss) - diluted	$	29,973		$	(2,832	)	$	29,359		$	(16,215	)

Diluted earnings (loss) per share:	$	0.78		$	(0.08	)	$	0.81		$	(0.46	)

Weighted average diluted shares outstanding (in thousands)⁴		38,481			35,255			36,463			35,037

ASTRONICS CORPORATION
CONSOLIDATED BALANCE SHEETS
($ in thousands)
	(unaudited)
	12/31/2025			12/31/2024
ASSETS
Current assets:
Cash and cash equivalents	$	18,180		$	9,285
Restricted cash		—			9,143
Accounts receivable, net of allowance of estimated credit losses		204,672			191,446
Inventories		196,860			199,741
Prepaid and other current assets		18,027			16,557
Total current assets		437,739			426,172
Property, plant and equipment, net of accumulated depreciation		107,078			80,687
Operating right-of-use assets		32,269			23,609
Other assets		11,316			7,763
Intangible assets, net of accumulated amortization		55,353			52,477
Goodwill		62,923			58,056
Total assets	$	706,678		$	648,764

LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	41,080		$	42,960
Current operating lease liabilities		5,802			4,697
Accrued expenses and other current liabilities		68,324			81,004
Customer advances and deferred revenue		26,069			27,491
Total current liabilities		141,275			156,152
Long-term debt		334,451			168,669
Long-term operating lease liabilities		38,101			20,508
Other liabilities		52,777			47,338
Total liabilities		566,604			392,667
Shareholders' equity:
Common stock		385			380
Accumulated other comprehensive loss		(4,410	)		(3,863	)
Other shareholders' equity		144,099			259,580
Total shareholders' equity		140,074			256,097
Total liabilities and shareholders' equity	$	706,678		$	648,764

ASTRONICS CORPORATION
CONSOLIDATED CASH FLOWS DATA
	Year Ended
(Unaudited, $ in thousands)	December 31, 2025			December 31, 2024
Cash flows from operating activities:
Net income (loss)	$	29,359		$	(16,215	)
Adjustments to reconcile net income (loss) to cash from operating activities:
Non-cash items:
Depreciation and amortization		21,838			24,466
Amortization of deferred financing fees		3,036			3,194
Provisions for non-cash losses on inventory and receivables		10,011			13,782
Equity-based compensation expense		6,799			8,571
Deferred tax benefit		(1,362	)		(20	)
Loss on settlement of debt		32,644			10,148
Operating lease non-cash expense		6,162			5,175
Simplification initiative-related non-cash charges		6,229			—
Non-cash 401K contribution and quarterly bonus accrual		—			3,454
Non-cash litigation provision adjustment		—			4,468
Other		(418	)		5,807
Cash flows from changes in operating assets and liabilities:
Accounts receivable		(8,102	)		(21,983	)
Inventories		(4,435	)		(21,551	)
Accounts payable		(3,114	)		(17,693	)
Accrued expenses		(15,027	)		21,987
Income taxes		(7,938	)		4,498
Operating lease liabilities		(4,573	)		(5,125	)
Tenant improvement allowance refund		8,138			—
Cloud computing implementation costs		(1,117	)		—
Customer advanced payments and deferred revenue		(4,189	)		5,693
Supplemental retirement plan liabilities		(716	)		(410	)
Other assets and liabilities		1,570			2,320
Net cash provided by operating activities		74,795			30,566
Cash flows from investing activities:
Capital expenditures		(31,673	)		(8,428	)
Acquisition of businesses, net of cash acquired		(22,075	)		—
Net cash used by investing activities		(53,748	)		(8,428	)
Cash flows from financing activities:
Proceeds from long-term debt		186,143			377,392
Principal payments on long-term debt		(111,143	)		(374,890	)
Proceeds from issuance of convertible debt		225,000			—
Partial repurchase of 2030 notes		(285,752	)		—
Payments for capped call transactions		(26,888	)		—
Financing-related costs		(10,366	)		(12,150	)
Financing settlement costs		—			(4,496	)
Stock award activity		753			(241	)
Other		(141	)		(145	)
Net cash used by financing activities		(22,394	)		(14,530	)
Effect of exchange rates on cash		1,099			(493	)
(Decrease) increase in cash and cash equivalents and restricted cash		(248	)		7,115
Cash and cash equivalents and restricted cash at beginning of year		18,428			11,313
Cash and cash equivalents and restricted cash at end of year	$	18,180		$	18,428
Supplemental disclosure of cash flow information
Interest paid	$	10,056		$	19,238
Income taxes paid, net of refunds	$	11,605		$	3,537
Non-cash investing activities:
Capital expenditures in accounts payable	$	2,025		$	—

ASTRONICS CORPORATION
SEGMENT SALES AND PROFIT
(Unaudited, $ in thousands)

	Three Months Ended						Year Ended
	12/31/2025			12/31/2024			12/31/2025			12/31/2024
Sales
Aerospace	$	219,593		$	188,559		$	797,353		$	706,746
Less inter-segment		—			(10	)		(34	)		(62	)
Total Aerospace		219,593			188,549			797,319			706,684

Test Systems		20,558			20,084			65,243			88,874
Less inter-segment		(84	)		(93	)		(434	)		(132	)
Total Test Systems		20,474			19,991			64,809			88,742

Total consolidated sales		240,067			208,540			862,128			795,426

Segment gross profit and margins⁵
Aerospace		74,604			55,909			248,440			204,126
		34.0	%		29.7	%		31.2	%		28.9	%
Test Systems		5,367			6,213			9,718			16,302
		26.2	%		31.1	%		15.0	%		18.4	%
Total gross profit		79,971			62,122			258,158			220,428

Segment operating profit and margins
Aerospace		41,734			16,778			113,204			62,406
		19.0	%		8.9	%		14.2	%		8.8	%
Test Systems		1,102			(49	)		(7,845	)		(8,477	)
		5.4	%		(0.2	)%		(12.1	)%		(9.6	)%
Total segment operating profit		42,836			16,729			105,359			53,929


Loss on settlement of debt		—			3,161			32,644			10,148
Interest expense		3,394			4,166			12,561			21,998
Corporate expenses and other		7,198			8,826			28,209			29,650
Income (loss) before taxes	$	32,244		$	576		$	31,945		$	(7,867	)

ASTRONICS CORPORATION
SALES BY MARKET
(Unaudited, $ in thousands)

	Three Months Ended						Year Ended						*2025 YTD* *% of Sales*
	12/31/2025		12/31/2024		% change		12/31/2025		12/31/2024		% change		*2025 YTD* *% of Sales*
Aerospace Segment
Commercial Transport	$	166,977	$	140,893	18.5	%	$	599,301	$	524,572	14.2	%	69.5	%
Military Aircraft		28,026		24,474	14.5	%		116,276		88,019	32.1	%	13.5	%
General Aviation		22,302		17,701	26.0	%		69,834		74,344	(6.1	)%	8.1	%
Other		2,288		5,481	(58.3	)%		11,908		19,749	(39.7	)%	1.4	%
Aerospace Total		219,593		188,549	16.5	%		797,319		706,684	12.8	%	92.5	%

Test Systems Segment
Government & Defense		20,474		19,991	2.4	%		64,809		88,742	(27.0	)%	7.5	%

Total Sales	$	240,067	$	208,540	15.1	%	$	862,128	$	795,426	8.4	%

SALES BY PRODUCT LINE
(Unaudited, $ in thousands)

	Three Months Ended						Year Ended						*2025 YTD* % *of Sales*
	12/31/2025		12/31/2024		% change		12/31/2025		12/31/2024		% change		*2025 YTD* % *of Sales*
Aerospace Segment
Electrical Power & Motion	$	113,841	$	95,124	19.7	%	$	410,382	$	359,043	14.3	%	47.6	%
Lighting & Safety		54,573		44,241	23.4	%		208,897		179,403	16.4	%	24.2	%
Avionics		31,970		36,467	(12.3	)%		123,422		120,183	2.7	%	14.3	%
Systems Certification		13,227		4,731	179.6	%		29,069		17,003	71.0	%	3.4	%
Structures		3,694		2,505	47.5	%		13,641		11,303	20.7	%	1.6	%
Other		2,288		5,481	(58.3	)%		11,908		19,749	(39.7	)%	1.4	%
Aerospace Total		219,593		188,549	16.5	%		797,319		706,684	12.8	%	92.5	%

Test Systems Segment		20,474		19,991	2.4	%		64,809		88,742	(27.0	)%	7.5	%

Total Sales	$	240,067	$	208,540	15.1	%	$	862,128	$	795,426	8.4	%

ASTRONICS CORPORATION
ORDER AND BACKLOG TREND
(Unaudited, $ in thousands)
	Q1 2025		Q2 2025		Q3 2025		Q4 2025		Trailing Twelve Months
	3/29/2025		6/28/2025		9/27/2025		12/31/2025		12/31/2025
Sales
Aerospace	$	191,375	$	193,626	$	192,725	$	219,593	$	797,319
Test Systems		14,561		11,052		18,722		20,474		64,809
Total Sales	$	205,936	$	204,678	$	211,447	$	240,067	$	862,128

Bookings
Aerospace	$	267,715	$	150,636	$	191,859	$	237,327	$	847,537
Test Systems		12,011		26,390		18,532		19,902		76,835
Total Bookings	$	279,726	$	177,026	$	210,391	$	257,229	$	924,372

Backlog⁶
Aerospace	$	613,903	$	570,913	$	572,459	$	600,803
Test Systems		59,116		74,454		74,264		73,692
Total Backlog	$	673,019	$	645,367	$	646,723	$	674,495		N/A

Book:Bill Ratio
Aerospace		1.40		0.78		1.00		1.08		1.06
Test Systems		0.82		2.39		0.99		0.97		1.19
Total Book:Bill		1.36		0.86		1.00		1.07		1.07

ASTRONICS CORPORATION
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA
(Unaudited, $ in thousands)

	Consolidated
	Three Months Ended						Year Ended
	12/31/2025			12/31/2024			12/31/2025			12/31/2024
Net income (loss)	$	29,615		$	(2,832	)	$	29,359		$	(16,215	)
Add back:
Interest expense		3,394			4,166			12,561			21,998
Income tax expense		2,629			3,408			2,586			8,348
Depreciation and amortization expense		5,709			5,894			21,838			24,466
Equity-based compensation expense		1,458			2,157			6,799			8,571
Early retirement penalty waiver		—			624			—			624
Non-cash 401K contribution and quarterly bonus accrual		—			—			—			3,454
Simplification and restructuring initiatives		—			1,411			6,867			2,444
Legal reserve, settlements and recoveries		—			4,762			9,732			4,430
Litigation-related legal expenses		1,875			6,066			8,873			19,746
Acquisition-related expenses		586			—			1,833			—
Loss on settlement of debt		—			3,161			32,644			10,148
Non-cash reserves for customer bankruptcy		—			1,032			—			3,235
Warranty reserve		407			1,690			1,446			5,217
Adjusted EBITDA	$	45,673		$	31,539		$	134,538		$	96,466

Sales	$	240,067		$	208,540		$	862,128		$	795,426
Adjusted EBITDA margin %		19.0	%		15.1	%		15.6	%		12.1	%

Adjusted EBITDA is defined as net income before interest expense, income taxes, depreciation, amortization, and other adjustments. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by sales. Adjusted EBITDA and Adjusted EBITDA Margin are not measures determined in accordance with GAAP and may not be comparable with Adjusted EBITDA and Adjusted EBITDA Margin as used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted EBITDA and Adjusted EBITDA Margin, are important for investors and other readers of the Company's financial statements.

ASTRONICS CORPORATION
RECONCILIATION OF OPERATING INCOME TO ADJUSTED OPERATING INCOME
(Unaudited, $ in thousands)

	Consolidated
	Three Months Ended						Year Ended
	12/31/2025			12/31/2024			12/31/2025			12/31/2024
Income from operations	$	35,462		$	8,876		$	76,412		$	26,466
Add back:
Simplification and restructuring initiatives		—			1,411			6,867			2,444
Legal reserve, settlements and recoveries		—			4,762			9,732			4,430
Litigation-related legal expenses		1,875			6,066			8,873			19,746
Acquisition-related expenses		586			—			1,833			—
Non-cash reserves for customer bankruptcy		—			1,032			—			3,235
Warranty reserve		407			1,690			1,446			5,217
Adjusted operating income	$	38,330		$	23,837		$	105,163		$	61,538

Sales	$	240,067		$	208,540		$	862,128		$	795,426

Operating margin		14.8	%		4.3	%		8.9	%		3.3	%
Adjusted operating margin		16.0	%		11.4	%		12.2	%		7.7	%

Adjusted Operating Income is defined as income from operations as reported, adjusted for certain items. Adjusted Operating Margin is defined as Adjusted Operating Income divided by sales. Adjusted Operating Income and Adjusted Operating Margin are not measures determined in accordance with GAAP and may not be comparable with Adjusted Operating Income and Adjusted Operating Margin as used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted Operating Income and Adjusted Operating Margin, are important for investors and other readers of the Company's financial statements and assists in understanding the comparison of the current quarter's and current year's income from operations to the historical periods' income from operations and operating margin, as well as facilitates a more meaningful comparison of the Company's income from operations and operating margin to that of other companies.

ASTRONICS CORPORATION
RECONCILIATION OF NET INCOME AND DILUTED EARNINGS PER SHARE
TO ADJUSTED NET INCOME AND ADJUSTED DILUTED EARNINGS PER SHARE
(Unaudited, $ in thousands, except per share amounts)

	Consolidated
	Three Months Ended						Year Ended
	12/31/2025			12/31/2024			12/31/2025			12/31/2024
Net income (loss)	$	29,615		$	(2,832	)	$	29,359		$	(16,215	)

Add back (deduct):
Amortization of intangibles		2,909			3,143			11,505			12,871
Simplification and restructuring initiatives		—			1,411			6,867			2,444
Early retirement penalty waiver		—			624			—			624
Legal reserve, settlements and recoveries		—			4,762			9,732			4,430
Litigation-related legal expenses		1,875			6,066			8,873			19,746
Acquisition-related expenses		586			—			1,833			—
Loss on settlement of debt		—			3,161			32,644			10,148
Non-cash reserves for customer bankruptcy		—			1,032			—			3,235
Warranty reserve		407			1,690			1,446			5,217
Normalize tax rate⁷		(6,876	)		(2,208	)		(23,625	)		(4,364	)
Adjusted net income	$	28,516		$	16,849		$	78,634		$	38,136

Convertible notes interest, net		358			590			5,409			590
Adjusted net income - diluted	$	28,874		$	17,439		$	84,043		$	38,726

Weighted average diluted shares outstanding (in thousands)⁸		38,481			35,255			36,463			35,037
Adjusted weighted average diluted shares outstanding (in thousands)⁸		38,481			37,779			41,903			36,022

Diluted earnings (loss) per share	$	0.78		$	(0.08	)	$	0.81		$	(0.46	)
Adjusted diluted earnings per share⁹	$	0.75		$	0.46		$	2.01		$	1.08

Adjusted Net Income and Adjusted Diluted EPS are defined as net income and diluted EPS as reported, adjusted for certain items, including amortization of intangibles, and also adjusted for a normalized tax rate. Adjusted Net Income and Adjusted Diluted EPS are not measures determined in accordance with GAAP and may not be comparable with the measures used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted Net Income and Adjusted Diluted EPS, are important for investors and other readers of the Company's financial statements and assists in understanding the comparison of the current quarter's and current year's net income and diluted EPS to the historical periods' net income and diluted EPS, as well as facilitates a more meaningful comparison of the Company's net income and diluted EPS to that of other companies. The Company believes that presenting Adjusted Diluted EPS provides a better understanding of its earnings power inclusive of adjusting for the non-cash amortization of intangible assets, reflecting the Company's strategy to grow through acquisitions as well as organically.

ASTRONICS CORPORATION
RECONCILIATION OF SEGMENT OPERATING PROFIT TO ADJUSTED SEGMENT OPERATING PROFIT
(Unaudited, $ in thousands)

	Three Months Ended						Year Ended
	12/31/2025			12/31/2024			12/31/2025			12/31/2024

Aerospace operating profit	$	41,734		$	16,778		$	113,204		$	62,406
Simplification and restructuring initiatives		—			—			6,508			237
Legal reserve, settlements and recoveries		—			4,762			9,732			4,430
Litigation-related legal expenses		1,409			5,966			7,311			19,127
Non-cash reserves for customer bankruptcy		—			1,032			—			3,235
Warranty reserve		407			1,690			1,446			5,217
Adjusted Aerospace operating profit	$	43,550		$	30,228		$	138,201		$	94,652

Aerospace sales	$	219,593		$	188,549		$	797,319		$	706,684

Aerospace margin		19.0	%		8.9	%		14.2	%		8.8	%
Adjusted Aerospace margin		19.8	%		16.0	%		17.3	%		13.4	%

Test Systems operating profit (loss)	$	1,102		$	(49	)	$	(7,845	)	$	(8,477	)
Simplification and restructuring initiatives		—			1,411			359			2,207
Litigation-related legal expenses		186			100			994			619
Adjusted Test Systems operating profit (loss)	$	1,288		$	1,462		$	(6,492	)	$	(5,651	)

Test Systems sales	$	20,474		$	19,991		$	64,809		$	88,742

Test Systems margin		5.4	%		(0.2	)%		(12.1	)%		(9.6	)%
Adjusted Test Systems margin		6.3	%		7.3	%		(10.0	)%		(6.4	)%

Adjusted Segment Operating Profit is defined as segment operating profit as reported, adjusted for certain items. Adjusted Segment Margin is defined as Adjusted Segment Operating Profit divided by segment sales. Adjusted Segment Operating Profit and Adjusted Segment Margin are not measures determined in accordance with GAAP and may not be comparable with Adjusted Segment Operating Profit and Adjusted Segment Margin as used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted Segment Operating Profit and Adjusted Segment Margin, are important for investors and other readers of the Company's financial statements and assists in understanding the comparison of the current quarter's and current year's segment operating profit to the historical periods' segment operating profit and segment margin, as well as facilitates a more meaningful comparison of the Company's segment operating profit and segment margin to that of other companies.


¹ Adjusted EBITDA, adjusted EBITDA margin, and adjusted segment operating margin are Non-GAAP financial measures. Please see the reconciliation of GAAP to non-GAAP financial measures in the tables that accompany this release.

² Adjusted operating income, adjusted operating margin, adjusted segment operating profit, adjusted segment operating margin, adjusted EBITDA, adjusted EBITDA margin, adjusted net income and adjusted diluted earnings per share ("EPS") are Non-GAAP financial measures. Please see the reconciliation of GAAP to non-GAAP financial measures in the tables that accompany this release.

³ During the first quarter of 2025, the Company changed its financial statement presentation of research and development costs. These costs were previously included within Cost of Products Sold and were a factor in arriving at Gross Profit. The prior period amounts for Cost of Product Sold and Gross Profit have been adjusted from their original presentation for comparability purposes.

⁴ In addition to incremental shares from stock awards, weighted average diluted shares for the quarter ended December 31, 2025 reflects 1.442 million shares underlying the remaining 5.5% convertible bonds. For the year ended December 31, 2025, the diluted EPS calculation excludes the effect of the 5.5% Notes because the effect is anti-dilutive.

No weighted average diluted shares were associated with the 0% convertible bonds because the average share price for both the quarter and year ended December 31, 2025 was below the $54.87 stated conversion price. Note that because of the capped call, there is no effective dilution to shareholders unless and until the share price exceeds $83.41.

⁵ During the first quarter of 2025, the Company changed its financial statement presentation of research and development costs. These costs were previously included within Cost of Products Sold and were a factor in arriving at Gross Profit. The prior period amounts for Cost of Product Sold and Gross Profit have been adjusted from their original presentation for comparability purposes.

⁶ Aerospace backlog of approximately $2.4 million and $10.6 million was added in the third and fourth quarters of 2025, respectively, in connection with the acquisitions of Envoy Aerospace and Bühler Motor Aviation.

⁷ Applies a normalized tax rate of 25% to GAAP pre-tax income and non-GAAP adjustments above, which are each pre-tax.

⁸ In addition to incremental shares from stock awards, weighted average diluted shares for the quarter ended December 31, 2025 reflects 1.442 million shares underlying the remaining 5.5% convertible bonds. For the year ended December 31, 2025, the diluted EPS calculation excludes the effect of the 5.5% Notes because the effect is anti-dilutive.

No weighted average diluted shares were associated with the 0% convertible bonds because the average share price for both the quarter and year ended December 31, 2025 was below the $54.87 stated conversion price. Note that because of the capped call, there is no effective dilution to shareholders unless and until the share price exceeds $83.41.

⁹ Net income for purposes of calculating adjusted diluted earnings per share includes addback of interest expense on the 5.5% convertible notes, net of income taxes, as required under the if-converted method.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260224562769/en/

For more information, contact:

Company:

Nancy L. Hedges, Chief Financial Officer

Phone: (716) 805-1599

Email: nancy.hedges@astronics.com

Investor Relations:

Deborah K. Pawlowski, Alliance Advisors LLC

Phone: (716) 843-3908

Email: dpawlowski@allianceadvisors.com

Astronics Corporation Reports Strong Fourth Quarter Finish to 2025